Luke V. Schneider

Target Discovery, Inc. provides scientific research services. It discovers, validates, and utilizes protein isoforms to improve clinical diagnosis and the management of diseases. The firm’s products address prostate cancer aggressiveness, and chemotherapy selection in breast and ovarian cancer. The company was founded by Luke V. Schneider in 1999 and is headquartered in Palo Alto, CA.

Aromyx Corp. engages in the using of biological receptors from the human nose to create digital representations of smell sensory data for multiple application. Its products include EssenceChip, EssenceCapture, EssenceAnalytics, and EssenceCloud. The company was founded by Chris Hanson and is headquartered in Palo Alto, CA.

Pangene Corp. develops oncology drugs based on its DNA repair and recombination platform. The company is headquartered in Mountain View, CA.

SRI International provides contract research and development services. It is an independent, nonprofit research institute conducting client-sponsored research and development for government agencies, commercial businesses, foundations, and other organizations. The company was founded in 1946 and is headquartered in Menlo Park, CA.